Privia Health Group (NASDAQ:PRVA) Price Target Raised to $24.00

Privia Health Group (NASDAQ:PRVA – Free Report) had its price target lifted by Robert W. Baird from $23.00 to $24.00 in a report issued on Monday, Benzinga reports. The firm currently has an outperform rating on the stock. Several other equities analysts also recently weighed in on the company. Barclays decreased their target price on […]

Leave a Reply

Your email address will not be published.

Previous post Coterra Energy Inc. (NYSE:CTRA) Receives $33.56 Consensus Price Target from Analysts
Next post Rezolute (NASDAQ:RZLT) Research Coverage Started at Guggenheim